Company Filing History:
Years Active: 2020-2023
Title: Mark Larson: Innovator in Medical Implant Technology
Introduction
Mark Larson is a notable inventor based in Lone Tree, Colorado, recognized for his contributions to medical technology. He has been instrumental in developing innovative solutions for securing tissue to bone, which are critical in various surgical procedures. With a total of two patents to his name, Larson's work reflects a commitment to advancing healthcare through engineering.
Latest Patents
Larson's latest patents include a fixation member with a separate eyelet and methods of use thereof. This patent describes an implant system designed for securing tissue to bone. The system features a first fixation member that is releasably engaged to a first inserter, which has a throughbore for accepting a filament. Additionally, it includes a cannulation that extends from the proximal to the distal end of the fixation member. The first inserter is positioned through this cannulation, with a distal tip extending beyond the fixation member's distal end. Furthermore, a second fixation member is also included, which is releasably engaged to a different inserter and is sized to fit within a bonehole.
Career Highlights
Mark Larson is currently employed at Stryker Corporation, a leading company in medical technology. His role involves collaborating with other professionals to develop innovative medical devices that enhance patient outcomes. His work is characterized by a focus on practical applications of engineering principles in the medical field.
Collaborations
Larson has worked alongside Kyle Craig Pilgeram, contributing to the development of advanced medical solutions. Their collaboration highlights the importance of teamwork in driving innovation within the industry.
Conclusion
Mark Larson's contributions to medical technology through his patents and work at Stryker Corporation exemplify the impact of innovation in healthcare. His dedication to improving surgical techniques through engineering continues to benefit patients and the medical community.